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Abstract. The influence of alkaline and the neutral grade of magnesium aluminometasilicate as a porous
solid carrier for the liquid self-emulsifying formulation with ibuprofen is investigated. Ibuprofen is
dissolved in Labrasol, then this solution is adsorbed on the silicates. The drug to the silicate ratio is 1:2,
1:4, and 1:6, respectively. The properties of formulations obtained are analyzed, using morphological,
porosity, crystallinity, and dissolution studies. Three solid self-emulsifying (S-SE) formulations containing
Neusilin SG2 and six consisting of Neusilin US2 are in the form of powder without agglomerates. The
nitrogen adsorption method shows that the solid carriers are mesoporous but they differ in a specific
surface area, pore area, and the volume of pores. The adsorption of liquid SE formulation on solid silicate
particles results in a decrease in their porosity. If the neutral grade of magnesium aluminometasilicate is
used, the smallest pores, below 10 nm, are completely filled with liquid formulation, but there is still a
certain number of pores of 40–100 nm. Dissolution studies of liquid SEDDS carried out in pH=1.2 show
that Labrasol improves the dissolution of ibuprofen as compared to the pure drug. Ibuprofen dissolution
from liquid SE formulations examined in pH of 7.2 is immediate. The adsorption of the liquid onto the
particles of the silicate causes a decrease in the amount of the drug released. Finally, more ibuprofen is
dissolved from S-SE that consist of the neutral grade of magnesium aluminometasilicate than from the
formulations containing the alkaline silicate.
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INTRODUCTION
In the recent years, the adsorption of lipid drug formula-
tions onto porous solid carriers has been the aim of several
studies (1–16). It is known that in the case of insoluble drugs,
an ideal solid carrier should have a high loading capacity, no
toxicity, no negative impact on the drug stability, and assure
complete drug release in the gastrointestinal tract. The pro-
cess of liquid adsorption on mesoporous solid carriers should
also be easy to scale-up.
The functionality of pharmaceutical mesoporous silicates,
such as silicon dioxide, calcium silicate, or magnesium
aluminometasilicate in the preparation of solid self-
emulsifying (S-SE) drug delivery systems with lansoprazole
or gentamycin sulfate of improved bioavailability have been
reported (9,10).
With regard to ibuprofen, a controlled drug delivery has
been obtained by soaking the synthetic silicates, such as TUD-
1, MCM-41, or SBA-15 in hexane and ethanol drug solution or
by co-spray drying (13–16). Moreover, the modification of the
synthetic silicate surface by amino functional or another alka-
line group was also found suitable to control the release rate
of acidic drugs (16). The pore size and specific surface area of
the solid carrier determined both the drug release rate and the
silicate loading capacity (6,9–11,15,16).
The previous studies on the physical mixtures, composed
of ibuprofen and the neutral grade of magnesium
aluminometasilicate, showed that the silicate protected ibu-
profen from evaporation at high temperatures (17). It was due
to the formation of a salt in the reaction between the carboxyl
group of ibuprofen and the hydroxyl groups from the surface
of Neusilin US2. The reaction was initiated by blending the
drug and the excipient at room temperature. Similarly, the
beneficial effect of magnesium aluminometasilicates on the
stability of amorphous quinapril hydrochloride after storage
at high humidity has been reported (18). Several studies have
also been carried out on the amorphization of crystalline drugs
by co-grinding with silicates (19).
In general, liquid lipid formulations destined to be
adsorbed on solid carriers are multicomponent and they are
composed of an oil phase, surfactant, and co-surfactant (1,2).
The presence of many liquid excipients in solidified formula-
tions may cause problems during compression, capsule filling,
or granulation (2–4). Moreover, due to the high viscosity of
the lipid formulation, the application of organic solvents may
be necessary for effective impregnation of the carrier (15,16).
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Thus, only a few reports deal with the analysis of S-SE for-
mulations composed of one liquid excipient, in which an in-
soluble active ingredient (API) is dissolved or dispersed
(9,10).
Several reports focus on the functionality of Labrasol to
improve the dissolution and bioavailability of poorly water
soluble drugs (2,9–11). Labrasol forms micelles in water,
which results in improved solubility of the API. The fluidity
of the gastric and intestinal mucosa increases, and the drug
bioavailability is higher (9). It has been shown that Labrasol
improves the solubility of ibuprofen from 0.02 mg/mL to
almost 150 mg/mL (20).
Furthermore, there are no scientific reports on the influ-
ence of magnesium aluminometasilicates as carriers that differ
in pH on the preparation of the solid SE powder with ibupro-
fen. In the present study, the lipid formulation to be adsorbed
on the silicate surface is composed of only one liquid excipi-
ent. Labrasol as a non-toxic, non-ionic surfactant of self-
emulsifying properties is used as a solvent for ibuprofen. It
consists of a mixture of PEG-8 caprylic/capric glycerides that
has wetting and solubilizing properties.
Therefore, the aim of the present study is to prepare S-SE
formulation with ibuprofen in the powder form by the adsorp-
tion of the drug solution in Labrasol onto particles of either
t h e n e u t r a l o r a l k a l i n e g r a d e o f m a g n e s i um
aluminometasilicate. Attention is paid to using a minimal
number of excipients during the manufacturing process. Since
the solubility of ibuprofen depends on pH, the influence of
carrier properties on the drug dissolution mechanism is inves-
tigated. S-SE systems are prepared by simple blending of the
drug solution with heated silicate powder. There are no or-
ganic solvents used for the carrier impregnation. The loading
capacity of silicates as well as the influence of the silicate grade
and Labrasol content on the possibility to obtain S-SE formu-
lation in powder form is analyzed.
MATERIAL AND METHODS
Ibuprofen (IBU) was purchased from Shasun Chemicals
and Drugs, India. Labrasol was supported by Gattefosse,
France. Two grades of magnesium aluminometasilicate, i.e.,
Neusilin US2 and Neusilin SG2, were kindly donated by Fuji
Chemical Industry, Japan. Hydrochloric acid 37% was obtain-
ed from Merck Millipore, Poland. Potassium dihydrogen
phosphate and sodium hydroxide of analytical grade were
purchased from Avantor Performance Materials Poland S.A.
Preparation of SE Formulations in Powder Form
Nine SE formulations containing either Neusilin SG2
(S1–S9) or Neusilin US2 (U1–U9) as a solid carrier were
prepared (Table I). Labrasol was heated at 60°C, using water
bath (LW-2, Poland) for 5 min. Its amount was 150, 300, or
600 μL, respectively. Then, 50 mg of ibuprofen was added and
the mixture was heated under stirring for 2 min until the drug
was dissolved. Magnesium aluminometasilicate was added
gradually to this solution. The amount of the carrier was 100,
200, or 300 mg. Stirring continued until the mixture was uni-
form. After cooling, the formulations were stored at the am-
bient temperature for 24 h, then they were passed through a
500-μm mesh sieve.
Six physical mixtures containing ibuprofen and Neusilin
SG2 (MS1–MS3) or Neusilin US2 (MU1–MU3) in 1:2, 1:4,
and 1:6 ratio were also prepared as a reference. The drug was
dry-blended with the silicate in a mortar for 2 min.
Morphological Studies
The morphology of ibuprofen and both grades of magne-
sium aluminometasilicates were analyzed using the scanning
electron microscope (SEM) Hitachi S-4700 (Japan). The pow-
der was adhered to the sample holder by a double-sided
copper tape. Its surface was coated with carbon using 208
HR carbon sputter coater (Cressington, USA). Images were
taken at ×400 and ×1000 magnification.
In order to analyze the texture of the sample surface,
SEM FEI Quanta 3D FEG (USA) in low vacuum mode
(80 Pa water) with electron energy 30 keV was used. Images
were taken at ×1000 and ×250,000 magnification.
The morphology of the samples prepared was also ana-
lyzed, using the CCD camera (DSC-W50, Sony, China).
Texture Analysis
A specific surface area, pore surface area, volume, and
pore size distribution of magnesium aluminometasilicates as
well as S-SE samples were determined by the nitrogen
adsorption/desorption method. The experiments were per-
formed at 77 K, using the volumetric analyzer ASAP 2010
(Micromeritics, USA).
Prior to the adsorption, the samples were degassed at
313 K for 26 h in vacuum conditions. A specific surface area
was determined from the adsorption isotherms by applying
the Brumauer-Emmett-Teller (BET) and Langmuir equations
in the relative range of pressure 0.05<p/p0<0.25, taking the
cross-section area of the nitrogen molecule to be 16.2 Å2 (21).
The mesopore surface area, the mean mesopore volume,
and the mesopore size distribution in the range from 1.7 to
300 nm were determined, using the Barret-Joyner-Halenda
(BJH) method and ASAP 2010 v.3.02 software (22). In the
BJH method, it is assumed that the physical adsorption of
nitrogen on the pore walls at the liquid nitrogen temperature
and the capillary condensation are mechanisms that determine
an equilibrium between the gas phase and the adsorbed phase
during nitrogen desorption. There is a relationship between
thickness of physically adsorbed layer and relative pressure.
Therefore, nitrogen desorption isotherms can be used to cal-
culate the distribution of mesopore volume and area with
respect to pore radius (22).
The micropore surface area and pore volume were calcu-
lated with t-plot method. In this method, the experimental test
isotherm is redrawn as a t-curve, in which the volume of gas
adsorbed is plotted versus the standard multilayer thickness
(t) of the reference non-porous material at the corresponded
p/p0. The differences between the shape of the experimental
isotherm and the standard isotherm give the information
about the micropore volume and micropore surface area (23).
X-ray Powder Diffraction
The samples of ibuprofen, silicates as well as formulations
prepared were analyzed by X-ray powder diffraction (XRPD).
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Table I. Consistency of S-SE With Ibuprofen. Images Taken by CCD Camera
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The measurements were performed using Philips X’Pert
APD diffractometer. The samples were exposed to X-ray
radiation (Cu-Kα) with the wavelength of 2 Å and a 0.02-
mm Ni-filter. The X-Ray tube was set up at a voltage of
45 kV and a current of 40 mA. The rate of the scanning
was 0.02°/min at a range of 2–60 2Θ.
Dissolution Studies and Kinetic Analysis
Ibuprofen release from SE powder was examined in the
automated pharmacopoeial paddle dissolution apparatus
Hanson Research Dissolution Station SR8 Plus with the
autosampling device Dissoette II (USA). A sample of liquid
SE formulation or powder containing 10 mg of ibuprofen was
used for the study to assure sink conditions. The dissolution
test was performed in 1000 mL of HCl 0.1 mol/L or phosphate
buffer of pH=7.2 prepared according to Ph. Eur. 8th edition at
37°C±0.5°C. The paddle rotation speed was set at 50 rpm. The
samples of 5 mL (n=3) were withdrawn through the polyethylene
filter (10 μm). The amount of ibuprofen dissolved was deter-
mined spectrophotometrically, using UV–VIS spectrophoto-
meter Jasco VT-530 (Japan) at 223 nm wavelength. Standard
deviation (SD) and relative standard deviation (RSD) were
calculated.
KinetDS 3.0 free license software was used to determine
the kinetics of ibuprofen dissolution (24). The dissolution
curves were fitted to the zero order, first order, Korsmeyer-
Peppas, Michaelis-Menten, Hixson-Crowell, and Higuchi
mathematical models (24,25). The goodness of fit was evalu-
ated using one-way ANOVA test to determine if the differ-
ences between the coefficients of determination (r2) are
statistically significant (P<0.05) as well as by chi-square test
(χ2) with established critical chi-square value of 0.7102 (lower-
tail) for α=0.05 and degrees of freedom (df) equal to 4. The
null hypothesis was tested if there were no statistically signif-
icant differences between models’ fitted curves and observed
dissolution points. Moreover, to select the best model within
the formulation, Akaike information criteria (AIC) parameter
was calculated by KinetDS3.0 software (24).
The model-independent parameters, such as dissolution
efficiency (DE) and mean dissolution time (MDT) were also















Q Amount (%) of the drug released at the time (t)
Qmax Maximum amount of the drug released (=100%)




The samples of SE powder were analyzed for transmit-
tance using the UV–VIS spectrophotometer Jasco VT-530
(Japan) at 520 nm wavelength. Prior to the measurement,
the samples corresponding to 50 mg of ibuprofen were dis-
persed in 900 mL of distilled water under continuous stirring
at 37°C and 50 rpm. The transmittance was measured in
triplicate after 60 min. The one-way ANOVA test was applied
to evaluate the differences between transmittance values for
different formulations. The significance was assumed, if P
value was below 0.05.
RESULTS AND DISCUSSION
Taking into account the advantages of solid dosage forms
in comparison to liquids as well as a beneficial effect of meso-
porous silicates on ibuprofen dissolution and stability, the
opportunity to convert ibuprofen solution in Labrasol into
SE powder, using either the alkaline or neutral grade of
magnesium aluminometasilicate, is examined in the present
study.
Magnesium aluminometasilicates are excipients certified
to be used in pharmaceutics, which are manufactured on an
industrial scale (16). Many of other porous carriers of well-
defined pore size and much higher specific surface area, i.e.,
SBA-15 or MCM-41 are synthetized at the laboratory scale so
as it may be difficult to use them in commercial technologies.
Furthermore, their application for the drug delivery at an
industrial scale may be limited, especially if a multistage or-
ganic solvent impregnation is necessary. Therefore, detailed
characteristics of commercially available mesoporous amor-
phous carriers as well as a single-stage impregnation technol-
ogy can be helpful during the development of either
innovative or generic drugs.
Sample Characterization
The results presented in Table I show that the consistency
of samples changes from liquid to semi-solid and finally solid
with decreasing Labrasol content and increasing the silicate
amount.
Among eighteen formulations prepared, thirteen are in
the powder form (Table I). Two formulations, S2 and U2, are
semi-solid, and three formulations, S3, S6, and U3, are liquid.
An increase in Labrasol amount from 150 to 300–600 μL
results in the formation of agglomerates.
In general, a higher amount of liquid formulation is
adsorbed if Neusilin US2 is used as a solid carrier in compar-
ison to Neusilin SG2. Seven out of nine formulations U are
solid (Table I). The application of Neusilin SG2 enables to
obtain only three S-SE formulations without agglomerates,
i.e., S4, S7, and S8. The presence of agglomerates is visible in
three other solid samples such as S1, S5, and S9.
Taking into account the amount of the solid carrier, it has
been shown that all the formulations containing 300 mg of the
silicate are solid. If 200 or 100 mg of the silicate is used, the
consistency of the sample depends on the kind of the silicate.
The differences in consistency can result from the physico-
chemical properties of Neusilin US2 and SG2. Agarwal et al. (7)
report that liquid SE formulation is usually adsorbed on the
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surface of a solid carrier but it is also filled in its pores. Therefore,
the effectiveness of the adsorption process depends on the particle
size of the carrier and its specific surface area.
Two grades of spray-dried magnesium aluminometasilicates
investigated in the present study are spherical granules that differ in
particle size (Fig. 1). Particles ofNeusilinUS2 are about three times
smaller than Neusilin SG2.
The poro s i t y o f bo th g rade s o f magne s ium
aluminometasilicate was examined by the nitrogen adsorption
method (Table II). The nitrogen adsorption and desorption
isotherms of the silicates form a distinct hysteresis loop, which
confirms the presence of mesopores in the samples (data not
shown here). According to IUPAC nomenclature, the diame-
ter of mesopores ranges from 1.7 to 50 nm.
The texture parameters calculated on the basis of nitro-
gen isotherms are provided in Table II. The specific surface
area of Neusilin US2 is twice as high as in Neusilin SG2, so is
the mesopore volume, which is more than twice as high
(Table II). The average mesopore diameter ranges from
12.85 to 14.47 nm, and Neusilin US2 has slightly bigger pores
than the alkaline grade. There is also a small volume of
micropores, i.e., pores <1.7 nm in diameter, in both excipients.
The micropore area of Neusilin US2 is 2.6-fold as high as in
Neusilin SG2.
The diffractograms of SE powders and their solid com-
ponents confirm the crystallinity of ibuprofen and the
amorphous form of both magnesium aluminometasilicates
(data not shown here). After the adsorption of drug solu-
tion, all the samples seem to be amorphous. The Bragg’s
peaks corresponding to crystalline ibuprofen in the range
from 6 to 40° at 2Θ are not found in solidified SE samples.
Similar results are obtained for the physical mixtures. Crys-
talline ibuprofen dry-blended with silicates is converted into
the amorphous form.
Fig. 1. SEM pictures of ibuprofen (a), Neusilin SG2 (b), and S4 (c). Low vacuum SEM pictures of Neusilin US2 (d, e) and U7 (f, g)
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The percentage of Wmax determines an amount of water
incorporated into the formulation, which causes a permanent
turbidity of the system (26). In the present study, distilled
water was being gradually added to 0.3 or 0.6 mL of the
surfactant. The mixture became turbid but turbidity disap-
peared during gentle stirring. The calculated values of Wmax
values for Labrasol ranged from 98.7 to 98.9% for 0.6 or
0.3 mL of the surfactant. The transmittance of samples was
16 and 18%, respectively. Dilution of the samples with water
resulted in an increase in their clarity. The transmittance of the
sample containing 0.3 mL of Labrasol and 900 mL of water
was 97%, whereas in the case of the mixture containing twice
as high as an amount of Labrasol, the transmittance was 90%.
The clarity of S-SE formulations after their dispersion in
water was analyzed by transmittance measurements. The re-
sults show that for all the formulations investigated, transmit-
tance ranges from 78 to 100%. The transmittance of placebo
formulations S1, S4-5, U1, U4-6, and U9 is similar to those
containing ibuprofen (P<0.05). Furthermore, the kind of the
carrier has no influence on the transmittance of SE powder
dispersed in water. An increase in the silicate content to
300 mg or/and adsorption of 600 μL of the liquid formulation
on its surface causes a decrease in the formulation clarity.
Formulations S9, U9, and U6 have the lowest transmittance,
ranging from 78 to 82%. The formulations containing the
lowest number of excipients have the highest transmittance
of about 100% and the best clarity.
Drug Release
It has been reported that the dissolution rate of the drug
from S-SE increases with the decreasing particle size of the
solid carrier (11). Small particles of a high specific surface area
have higher contact with SE formulation as compared to big
Table II. Texture of Magnesium Aluminometasilicates and Selected Solid SE Formulations Determined by Nitrogen Adsorption Method
Parameters Neusilin SG2 S4 Neusilin US2 U7
Amount of IBU per
1 g of sample
(wt%)
– 20 – 14




186.51 0.52 371.88 36.87
Micropore area, Smicro (m
2/g) 24.42 0.30 63.64 0
Mesopore volume, Vmezo
a (cm3/g) 0.6792 0.0002 1.5379 0.3247
Micropore volume, Vmicro (cm
3/g) 0.0096 0.00006 0.0267 0
Mesopore diameter, Dmezo
b (nm) 12.85 18.47 14.47 23.63
aBJH desorption cumulative pore volume in the range from 1.7 to 300 nm
bBJH desorption cumulative pore diameter in the range from 1.7 to 300 nm
Fig. 2. Influence of Labrasol content on ibuprofen dissolution from liquid SE formulations composed of 50
mg of ibuprofen and 150–600 μL of Labrasol: HCl 0.1 mol/L of pH=1.2 (a), phosphate buffer of pH=7.2 (b).
Error bars represent SD of three measurements
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particles. Ito et al. (9) described the properties of S-SE formu-
lations prepared by the adsorption of gentamycin sulfate dis-
persed in Labrasol on the surface of silicates, where the
specific surface area varied from 120 to 300 m2/g. SE powder
was then placed into hard gelatin capsules. The results of both
dissolution and bioavailability studies showed that the highest
amount of gentamycin was dissolved from the samples
containing the silicate of the lowest specific surface area, i.e.,
120 m2/g. They concluded that the carriers with a low specific
surface area could be more effective in dissolution rate
improvement as compared to the carriers of a high specific
surface area (9). Due to the fact that the porous carriers of a
high specific surface area may be less dispersed in the
gastrointestinal tract, API dissolution and adsorption can be
slower. Furthermore, if strong adsorbents are used to solidify
APIs solutions in Labrasol, the drug release rate can be
sustained (9).
In the present study, dissolution tests were carried out,
using two different solvents, such as HCl 0.1 mol/L without
pepsin of pH=1.2 and the pharmacopoeial phosphate buffer of
pH=7.2 recommended for ibuprofen. Since the solubility of
ibuprofen in pH=1.2 is very low, i.e., 0.038 mg/mL, drug dis-
solution studies in 0.1 mol/L HCl were performed with the aim
to determine if the presence of a self-emulsifying surfactant
and a silicate solid carrier could improve its dissolution.
The dissolution curves of liquid self-emulsifying formula-
tions are presented in Fig. 2. After 45 min, no more than 67%
of ibuprofen is released in pH=1.2 (Fig. 2a). In spite of the fact
that the application of Labrasol enables to improve signifi-
cantly (P<0.05) the amount of ibuprofen dissolved, the
dissolution improvement was the highest at the beginning of
the test. After 5 min, the amount of ibuprofen released was
from 15 to 45 times as high as in the pure drug. Finally,
after 45 min, the amount of the drug dissolved increased
from about four to seven times with the increasing
amount of Labrasol in the formulation. Fine droplets of
SE lipid formulation have been visible until the end of the
dissolution test, which can confirm that not all ibuprofen
was dissolved after 45 min.
The dissolution profiles in the phosphate buffer show that
after 30 min, more than 80% of ibuprofen is dissolved from all
the liquid lipid formulations (Fig. 2b). This fact may indicate
an immediate drug release.
The dissolution curves of S-SE formulations and physical
mixtures in HCl 0.1 mol/L are shown in Fig. 3. The results
confirm that the kind of the silicate and the content of
Labrasol in the S-SE formulation have influence on the ibuprofen
release rate. After 45 min, the highest amount of ibuprofen, i.e.,
more than 50%, dissolved from samples U7 and U8, containing
Neusilin US2 (Fig. 3a–c). The amount of ibuprofen dissolved
from formulations S was lower (Fig. 3d, e). In such a case,
the best properties were observed in formulation S4, from
which more than 40% of the drug was dissolved in
pH=1.2 after 45 min (Fig. 3d).
The model-independent parameters such as mean disso-
lution time (MDT) and dissolution efficiency (DE), calculated
on the basis of ibuprofen dissolution profiles in HCl 0.1 mol/L,
show that formulation S4 has the shortest MDT such as 7 min
and the highest DE of 37% (Table III). The comparison of the
model-independent parameters between S4 and S7 reveals
Fig. 3. Dissolution profiles of S-SE formulations containing Neusilin SG2 (a, b, c) and Neusilin US2 (d, e) as solid carrier in pH=1.2. Error bars
represent SD of three measurements
629Preformulation Studies on Self-Emulsifying Powder with Ibuprofen
that an increase in the silicate content from 200 to 300 mg
causes an approximately twofold increase in MDT, i.e., from 7
to 14 min and an 18-fold decrease in ibuprofen DE which is
only of 2%. If the content of the silicate is the same (S7 and
S8), but if there is twice more liquid SE formulation adsorbed
(S8), DE can be higher such as 9%.
DE and MDT values for solid self-emulsifying samples
containing Neusilin US2 depend also on the silicate content
and the amount of liquid formulation incorporated into the
solid carrier (Table III). The analysis of the formulation U4
and U5 shows that a twofold increase in the amount of
Labrasol causes an almost twofold decrease in DE but MDT
is similar. However, the analysis of SE powders U7 and U8
shows similar results to U4, i.e., MDT of about 8 min and DE
of about 48%. If there is 300 mg of the silicate, an increase in
Labrasol content to 600 μL causes a decrease in DE from 48 to
30%, but MDT is still about 8 min.
The dissolution of S-SE consisting of Neusilin US2, ex-
amined in HCl 0.1 mol/L, shows better results as compared to
the physical mixtures (Fig. 3; Table III). For the majority of U
samples, MDT is shorter and the dissolution efficiency is
higher than for MU. The results for the physical mixtures
composed of ibuprofen and Neusilin SG2 indicate that except
for S4, DE is lower than S-SE (Table III).
Furthermore, the comparison of dissolution profiles for
formulations U1, U4, and U7 containing 100, 200, and 300 mg
of Neusilin US2 reveals that MDT decreases but the dissolu-
tion rate based on diffusion (K) and DE increases with in-
creasing the silicate content (Fig. 4).
In order to explain the drug dissolution mechanism, the
dissolution profiles were fitted to the zero order, first order,
Korsmeyer-Peppas, Michaelis-Menten, Higuchi, and Hixson-
Crowell mathematical models (24,25). The highest values of co-
efficients of determination (r2) were found for three of these
models, i.e., the zero order, Korsmeyer-Peppas, and Hixson-
Crowell. The one-way ANOVA test was performed for each
dissolution profile to evaluate if the values of r2 calculated for
the threemodels are significantly different (Table III). The results
for S-SE containing Neusilin SG2 as a solid carrier indicate that
only in the case of formulation S7, the differences in r2 values are
significant (P<0.05). In such a case, the diffusion-based mecha-
nism of the drug release may be suggested.
Different results can be seen from Table III for Neusilin
US2. The coefficients of determination are significantly different
(P<0.05) for all S-SE formulations. The highest values of r2 may
suggest that ibuprofen can be dissolved by diffusion (r2 0.8494–
0.9342) rather than by the erosion-based mechanism (r2 0.6366–
0.7461) or the zero order kinetics (r2 0.6939–0.8140).
The goodness of fit was also evaluated using chi-square
(χ2) test and Akaike information criteria (AIC). The results
are shown in Table IV. For at least one model, seven
formulations, i.e., MS1, MS2, S4, S7, S8, MU3, and U9 have
lower chi-square values (χ2) than the critical value. For a given
formulation, the smallest AIC was used to select the most
appropriate model, giving the best fit. Korsmeyer-Peppas
model fits the best if Neusilin SG2 is used as a carrier, which
confirms that ibuprofen can dissolve by diffusion. However,
the mechanism of ibuprofen release from physical mixtures
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either zero order or diffusion based. Chi-square values for
formulations containing Neusilin US2 such as MU3 and U9
are lower than 0.7102 (Table IV). There are no statistically
significant differences between Korsmeyer-Peppas mathemat-
ical model and the data points. Therefore, regardless the
statistical test used to evaluate the goodness of fit, it is difficult
to draw a general conclusion with regard to ibuprofen disso-
lution mechanism.
Since ibuprofen is an organic acid and its dissolution
depends on pH, it seems that the application of an alkaline
solid carrier, i.e., Neusilin SG2, may be helpful to improve its
dissolution in low pH. Nevertheless, the results show that the
amount of ibuprofen dissolved from formulations S, prepared
using the alkaline solid carrier, is lower than from U samples,
containing neutral grade of magnesium aluminometasilicate.
These results are in agreement with the literature reports
(5,6,16,27). The loading of acidic drugs into amino-
functionalized mesoporous silica can be applied to suppress
the dissolution rate. This effect is due to strong interactions
between the amine and carboxylic group. Rosenholm and
Linden (27) claims that the result is pronounced if there is a
very high excess of amino functions on the silicate surface.
According to the data provided by the manufacturer, pH of
4% aqueous slurry prepared using Neusilin SG2 is from 8.5 to
10.0.
In the present study, a small amount of ibuprofen dis-
solved from formulations S can also be related to the differ-
ences in the texture of mesoporous carriers. SEM pictures of
Fig. 4. Influence of amount of Neusilin US2 on ibuprofen dissolution rate (K), MDT, and
DE from S-SEDDS








(χ2) P value AIC
Chi-square
(χ2) P value AIC Chi-square (χ2) P value AIC
MS1a 0.3701 0.9848 9.3379 0.6962 0.9518 15.1140 0.4494 0.9782 14.9412
MS2a 1.4042 0.8435 19.7460 0.3979 0.9826 12.4787 2.5938 0.6279 23.8383
MS3 6.0720 0.1938 17.6765 4.7267 0.3165 10.4169 8.0230 0.0907 22.1093
S4a 1.4469 0.8360 23.5059 0.5325 0.9703 18.4196 1.5980 0.8091 24.0722
S7a 0.7277 0.9479 16.4913 0.1042 0.9987 6.7114 1.1900 0.8797 19.4587
S8a 0.5251 0.9710 10.4454 0.2569 0.9924 7.3447 0.7267 0.9480 12.2412
MU1 4.0774 0.8501 12.8986 4.8705 0.7713 16.3994 5.9726 0.6503 19.8749
MU2 17.5402 0.1646 25.1937 8.7402 0.3647 21.1080 19.8549 0.0109 28.9917
MU3a 2.1128 0.9774 16.0404 0.3749 0.99996 4.0270 4.8600 0.7724 21.5308
U1 2.4624 0.6514 21.9602 1.1525 0.8859 17.9180 3.2355 0.5192 23.6819
U4 4.4397 0.3498 29.8802 2.1847 0.7018 26.1641 4.8154 0.2841 30.6033
U5 2.8595 0.5816 24.5784 1.3473 0.8533 20.6985 3.0608 0.4940 25.6116
U7 2.4575 0.6523 27.3513 0.8969 0.9250 22.2153 2.5769 0.5930 28.0965
U8 2.8666 0.5804 27.9286 1.1200 0.8911 23.0590 3.0936 0.5111 28.7315
U9a 1.7307 0.7851 23.2262 0.5975 0.9633 17.9756 1.7627 0.7276 24.2043
Chi-square critical value for α=0.05 (lower-tail) and degrees of freedom (df) equal to 4 is 0.7102
χ2 chi-square, P Value probability of null hypothesis acceptance, AIC Akaike Information Criterion
a discussed formulations, bolded values of models giving best fit
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solid self-emulsifying formulations S4 and U7 are presented in
Fig. 1. Particles of U7 are spherical, whereas the shape of S4
particles is irregular. The image analysis performed using the
high resolution scanning electron microscopy shows the pres-
ence of mesopores on the carrier surface. After impregnation
with liquid SE, the surface of the particles becomes smooth,
which can be due to the fact that the pores are filled. These
findings are in agreement with the results of texture analysis
obtained by nitrogen adsorption method.
The pore size distribution and the pore area of pure
magnesium aluminometasilicates and solid self-emulsifying
formulations S4 and U7 are shown in Figs. 5 and 6. It can be
seen from Figs. 5a and 6a that the pores of 20.3 nm in diameter
dominates in both Neusilin SG2 and Neusilin US2. Apart from
that, there are also pores in the range of 4–15 nm and 40–100
nm but the pore volume and the pore area of Neusilin SG2 are
more than twice as low as in Neusilin US2 (Figs. 5–6b–d,
Table II).
In the case of S4, the adsorption of 150 μL of the liquid
lipid formulation on 200 mg of Neusilin SG2 causes a
complete filling of pores (Fig. 5). The specific surface area,
SBET, for sample S4 is 0.52 m
2/g, whereas SBET for the pure
carrier is 186.51 m2/g (Table II). The texture analysis of
formulation U7, consisting of Neusilin US2, confirms that
the adsorption of the same amount of liquid formulation on
300 mg of the silicate results also in a decrease in the pore
volume as well as the pore area. SBET of formulation U7
decreases more than ten times in comparison to the pure
carrier (Table II). Figure 6 confirms that the pores below
10 nm and a half of the pores from 40 to 100 nm in Neusilin
US2 are filled with the liquid lipid formulation.
Figure 7 shows the dissolution profiles of the selected
solid self-emulsifying formulations in phosphate buffer of
pH=7.2. The release of ibuprofen from the physical mixtures
MU3 and MS3 as well as the dissolution of the pure drug is
immediate (more than 80% in 5 min). In spite of this, the
sustained release of ibuprofen was obtained from all S-SE.
Among the formulations consisting of Neusilin US2, the
highest amount of ibuprofen, i.e., more than 70%, was dis-
solved after 45 min from U7. The higher amount of the liquid
Fig. 5. Pore size distribution (a), cumulative pore volume (b), pore area distribution (c), and cumulative pore area (d) in Neusilin SG2 (white
bars and symbols) and S4 (grey bars and symbols)
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lipid formulation adsorbed on the solid carrier caused a de-
crease in the amount of ibuprofen dissolved to 60 or 40% for
U8 or U9, respectively (Fig. 7a). However, the dissolution
profiles of U4 and U7 indicate that an increase in the carrier
content can improve ibuprofen dissolution if the amount of
the liquid SE formulation is the same.
The amount of ibuprofen dissolved after 45 min from S4
and S7, containing Neusilin SG2, was lower, i.e., 50 and 40%,
respectively. In this case, an increase in the silicate content
caused a decrease in the drug release. It might be related to
strong interactions between the acidic drug and the alkaline
silicate or to the insufficient porosity of the carrier for the
effective wetting of the drug entrapped in its pores (Fig. 7b).
Therefore, the application of the neutral or alkaline meso-
porous magnesium aluminometasilicates as carriers for ibupro-
fen solutions in Labrasol may give the opportunity to obtain the
modified drug release. The advantage of such formulations is
the lack of the residual organic solvents and theminimal number
of the excipients used for their preparation (5,6,14,20,28).
CONCLUSIONS
The application of magnesium aluminometasilicate en-
ables to prepare S-SEDDS with amorphous ibuprofen, using
Labrasol as a lipid self-emulsifying excipient by simple blend-
ing of components. The application of an additional organic
solvent is not necessary to impregnate the solid carrier with
the liquid formulation, which is an important advantage.
The liquid lipid formulation is adsorbed in the pores of
silicates. The adsorption of the lowest amount of the liquid SE
causes the filling of all the pores in Neusilin SG2. It results in
the decrease in ibuprofen dissolution as the wetting of the
drug entrapped in the pores is more difficult. Strong interac-
tions between the carboxylic group of the drug and the surface
of the alkaline silicate may also sustain the release of acidic
drugs. Thus, the application of the neutral silicate can be more
effective for the dissolution rate improvement of ibuprofen.
The dissolution efficiency is the highest, i.e., 37–48% and
mean dissolution time is the shortest, i.e., about 8 min for
Fig. 6. Pore size distribution (a), cumulative pore volume (b), pore area distribution (c), and cumulative pore area (d) in Neusilin US2 (white
bars and symbols) and U7 (grey bars and symbols)
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samples S4 and U7. The amount of Labrasol in the formulation,
the physicochemical properties of both the drug, and the solid
carrier are critical parameters to optimize ibuprofen release.
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